PROTIVA BIOTHERAPEUTICS, INC.
Patent Owner
Stats
- 46 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 46 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,130 Total Citation Count
- Feb 02, 1999 Earliest Filing
- 23 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,397 NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORSNov 20, 17Mar 15, 18[A61K, C12N]
2017/0151,333 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOFSep 09, 16Jun 01, 17[A61K, C07D, C07C]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9878042 Lipid formulations for delivery of therapeutic agents to solid tumorsJan 27, 15Jan 30, 18[C07H, A61K, C12N]
9765333 Compositions and methods for silencing marburg virus gene expressionAug 21, 15Sep 19, 17[A61K, C12N]
9428751 Compositions and methods for silencing apolipoprotein C-III expressionApr 01, 15Aug 30, 16[A61K, C07H, B82Y, C12N]
9222086 Compositions and methods for silencing genes expressed in cancerSep 23, 10Dec 29, 15[A61K, C07H, C12Q, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0042,814 NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERYAbandonedMay 25, 16Feb 16, 17[A61K, C12N]
2016/0256,567 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAAbandonedMay 12, 16Sep 08, 16[A61K]
2016/0256,568 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAAbandonedMay 12, 16Sep 08, 16[A61K]
2014/0288,146 NOVEL TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOFAbandonedApr 25, 13Sep 25, 14[A61K, C07C]
2013/0178,511 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNAAbandonedJul 17, 12Jul 11, 13[C12N]
2013/0122,104 NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORSAbandonedAug 03, 12May 16, 13[A61K]
2013/0123,338 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOFAbandonedMay 12, 11May 16, 13[A61K, C07D, C07C]
2012/0058,188 LIPID ENCAPSULATED INTERFERING RNAAbandonedJun 24, 11Mar 08, 12[A61K, B82Y, C12N, A61P]
2011/0313,017 SNALP FORMULATIONS CONTAINING POLYOXAZOLINE-DIALKYLOXYPROPYL CONJUGATESAbandonedJan 13, 11Dec 22, 11[A61K, C12N]
2011/0177,131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSIONAbandonedSep 09, 10Jul 21, 11[A61K, C07H, B82Y, A61P]
2011/0071,208 LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNAAbandonedJun 04, 10Mar 24, 11[A61K, C12N, A61P]
2008/0171,716 NUCLEIC ACID MODULATION OF TOLL-LIKE RECEPTOR-MEDIATED IMMUNE STIMULATIONAbandonedAug 15, 07Jul 17, 08[A61K, C07H, A61P]
2007/0218,122 siRNA silencing of influenza virus gene expressionAbandonedNov 17, 06Sep 20, 07[A61K, C07H]
2007/0054,873 Glucocorticoid modulation of nucleic acid-mediated immune stimulationAbandonedAug 28, 06Mar 08, 07[A61K]
2006/0051,405 Compositions for the delivery of therapeutic agents and uses thereofAbandonedJul 19, 05Mar 09, 06[A61K, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.